These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 4239477

  • 1. [The thrombolytic medications].
    Rignault D.
    Presse Med (1893); 1969 Jan 11; 77(2):55-8. PubMed ID: 4239477
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Further experience with "minidosage" in fibrinolytic treatment.
    Heikinheimo R, Ruosteenoja R.
    Curr Ther Res Clin Exp; 1971 Jul 11; 13(7):444-50. PubMed ID: 5000297
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Streptodecase-2 in the treatment of acute myocardial infarct, unstable stenocardia, thromboembolism and thrombosis].
    Butorov VN, Repinskaia NP, Demidova AV, Sysoeva NA, Kirichenko AA.
    Ter Arkh; 1990 Jul 11; 62(8):21-6. PubMed ID: 2274864
    [Abstract] [Full Text] [Related]

  • 10. Thrombolytic treatment of acute peripheral arterial and venous occlusions.
    Schmutzler R.
    Angiologica; 1968 Jul 11; 5(2):119-29. PubMed ID: 4232514
    [No Abstract] [Full Text] [Related]

  • 11. Perspectives: fibrinolysis and thrombolysis.
    Sherry S.
    Thromb Diath Haemorrh Suppl; 1966 Jul 11; 20():1-12. PubMed ID: 5973051
    [No Abstract] [Full Text] [Related]

  • 12. [Fibrinolytics. 46].
    Wagler M.
    Pharm Prax; 1970 Jul 11; 6():141-2. PubMed ID: 4195438
    [No Abstract] [Full Text] [Related]

  • 13. [Thrombolytic therapy].
    Schimpf K.
    Dtsch Med Wochenschr; 1969 Oct 31; 94(44):2292-4. PubMed ID: 5350098
    [No Abstract] [Full Text] [Related]

  • 14. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A, Vermylen J, Verstraete M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 Oct 31; 92(1):7-19. PubMed ID: 4189377
    [No Abstract] [Full Text] [Related]

  • 15. [Thrombolytic treatment of thromboembolytic conditions].
    Gormsen J.
    Ugeskr Laeger; 1966 Oct 20; 128(42):1235-45. PubMed ID: 4231392
    [No Abstract] [Full Text] [Related]

  • 16. [Thrombolytic therapy].
    Schmutzler R, Koller F.
    Ergeb Inn Med Kinderheilkd; 1965 Oct 20; 22():157-210. PubMed ID: 5889464
    [No Abstract] [Full Text] [Related]

  • 17. Fibrinolysis.
    Sherry S.
    Annu Rev Med; 1968 Oct 20; 19():247-68. PubMed ID: 4172727
    [No Abstract] [Full Text] [Related]

  • 18. Fibrinolytic guidelines in diabetes.
    Sharma GV, Mukerjee DK, Sasahara AA.
    Geriatrics; 1982 Apr 20; 37(4):38-42, 46. PubMed ID: 7060947
    [Abstract] [Full Text] [Related]

  • 19. [Fibrinolytic therapy of patients with pulmonary artery thromboembolism by tissue plasminogen activator and streptokinase preparations].
    Ardashev VN, Sokolianskiĭ NV, Bystrov VV.
    Klin Med (Mosk); 2000 Apr 20; 78(12):28-30. PubMed ID: 11210347
    [Abstract] [Full Text] [Related]

  • 20. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
    Bouvier CA, Berthoud S.
    Helv Med Acta; 1968 Mar 20; 34(2):170-86. PubMed ID: 4232105
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.